Citations (119)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Shuai Wang, Upendra A. Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D. Crouch, Deepika Dhaware, Carley J. S. Heck, Kevin M. Johnson, Amit S. Kalgutkar, Lloyd King, Joyce Liu, Bin Ma, Hlaing Maw, Grover P. Miller, Herana Kamal Seneviratne, Ryan H. Takahashi, Cong Wei & S. Cyrus Khojasteh. (2023) Bioactivation and reactivity research advances – 2022 year in review‡. Drug Metabolism Reviews 55:4, pages 267-300.
Read now
Read now
Anna Kerins, Marta Koszyczarek, Caroline Smith, Phil Butler, Rob Riley, Vamsi Madgula, Nilkanth Naik, Matthew R. Redinbo & Ian D. Wilson. (2022) The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652. Xenobiotica 52:8, pages 904-915.
Read now
Read now
Tao-Shun Zhou, Bin Wei, Min He, Ya-Sheng Li, Ya-Kun Wang, Si-Jia Wang, Jian-Wei Chen, Hua-Wei Zhang, Zi-Ning Cui & Hong Wang. (2020) Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli β-glucuronidase inhibitors and their structure–inhibitory activity relationships. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1736-1742.
Read now
Read now
Xing-Nuo Li, Lu-Xia Hua, Tao-Shun Zhou, Ke-Bo Wang, Yuan-Yuan Wu, Mahmoud Emam, Xiao-Ze Bao, Jun Chen & Bin Wei. (2020) Cinnamic acid derivatives: inhibitory activity against Escherichia coli β-glucuronidase and structure–activity relationships. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1372-1378.
Read now
Read now
Guillermo García-Rayado, Mercedes Navarro & Angel Lanas. (2018) NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Review of Clinical Pharmacology 11:10, pages 1031-1043.
Read now
Read now
Juanhong Zhang, Junmin Zhang & Rong Wang. (2018) Gut microbiota modulates drug pharmacokinetics. Drug Metabolism Reviews 50:3, pages 357-368.
Read now
Read now
Diego Currò. (2018) The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues. Expert Review of Clinical Pharmacology 11:2, pages 171-183.
Read now
Read now
Mohd Yaseen Malik, Swati Jaiswal, Abhisheak Sharma, Mahendra Shukla & Jawahar Lal. (2016) Role of enterohepatic recirculation in drug disposition: cooperation and complications. Drug Metabolism Reviews 48:2, pages 281-327.
Read now
Read now
Emmanouil Kyriakakis, Maria Markaki & Nektarios Tavernarakis. (2015) Caenorhabditis elegans as a model for cancer research. Molecular & Cellular Oncology 2:2.
Read now
Read now
Henry J Haiser, Kristen L Seim, Emily P Balskus & Peter J Turnbaugh. (2014) Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 5:2, pages 233-238.
Read now
Read now
Articles from other publishers (109)
Gouxin Huang, Raees Khan, Yilin Zheng, Ping-Chin Lee, Qingnan Li & Imran Khan. (2023) Exploring the role of gut microbiota in advancing personalized medicine. Frontiers in Microbiology 14.
Crossref
Crossref
Lars Weidolf & Ian Wilson. (2023) Minimizing the DILI potential of carboxylic acid-containing drugs: a perspective. Medicinal Chemistry Research.
Crossref
Crossref
Almut Heinken, Johannes Hertel, Geeta Acharya, Dmitry A. Ravcheev, Malgorzata Nyga, Onyedika Emmanuel Okpala, Marcus Hogan, Stefanía Magnúsdóttir, Filippo Martinelli, Bram Nap, German Preciat, Janaka N. Edirisinghe, Christopher S. Henry, Ronan M. T. Fleming & Ines Thiele. (2023) Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nature Biotechnology 41:9, pages 1320-1331.
Crossref
Crossref
M. Leonor Fernández-Murga, Fernando Gil-Ortiz, Lucía Serrano-García & Antonio Llombart-Cussac. (2023) A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target. Pathogens 12:9, pages 1086.
Crossref
Crossref
Archana Pant, Tushar K. Maiti, Dinesh Mahajan & Bhabatosh Das. (2022) Human Gut Microbiota and Drug Metabolism. Microbial Ecology 86:1, pages 97-111.
Crossref
Crossref
Jingjing Meng, Yaa F. Abu, Yue Zhang, Yuyin Zhou, Yun Xie, Yan Yan, Junyi Tao, Sundaram Ramakrishnan, Chi Chen & Sabita Roy. (2023) Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model. British Journal of Pharmacology 180:10, pages 1362-1378.
Crossref
Crossref
Carmen Purdel, Anca Ungurianu, Ines Adam-Dima & Denisa Margină. (2023) Exploring the potential impact of probiotic use on drug metabolism and efficacy. Biomedicine & Pharmacotherapy 161, pages 114468.
Crossref
Crossref
Amelia Y. M. Woo, Miguel A. Aguilar Ramos, Rohan Narayan, Khyle C. Richards-Corke, Michelle L. Wang, Walter J. Sandoval-Espinola & Emily P. Balskus. (2023) Targeting the human gut microbiome with small-molecule inhibitors. Nature Reviews Chemistry 7:5, pages 319-339.
Crossref
Crossref
Yorinobu Maeda & Teruo Murakami. (2023) Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth. Antibiotics 12:2, pages 263.
Crossref
Crossref
Huanhuan Cao, Yujie Zhu, Gaofei Hu, Qi Zhang & Lemin Zheng. (2023) Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?. Pharmacological Research 187, pages 106586.
Crossref
Crossref
Panpan Wang, Rongrong Wu, Yifei Jia, Puipui Tang, Bin Wei, Qingwen Zhang, Vivien Ya-Fan Wang & Ru Yan. (2022) Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases. International Journal of Biological Macromolecules 220, pages 1532-1544.
Crossref
Crossref
Marine P. M. Letertre, Aadra P. Bhatt, Michael Harvey, Jeremy K. Nicholson, Ian D. Wilson, Matthew R. Redinbo & Jonathan R. Swann. (2022) Characterizing the metabolic effects of the selective inhibition of gut microbial β-glucuronidases in mice. Scientific Reports 12:1.
Crossref
Crossref
Song Gao, Rongjin Sun, Rashim Singh, Sik Yu So, Clement T.Y. Chan, Tor Savidge & Ming Hu. (2022) The role of gut microbial β-glucuronidase in drug disposition and development. Drug Discovery Today 27:10, pages 103316.
Crossref
Crossref
Manon Jardou, Clarisse Brossier, Kenza Guiyedi, Quentin Faucher & Roland Lawson. (2022) Pharmacological hypothesis: A recombinant probiotic for taming bacterial β‐glucuronidase in drug‐induced enteropathy. Pharmacology Research & Perspectives 10:5.
Crossref
Crossref
Xing Lyu, Jieli Chen, Xingjie Gao & Jie Yang. (2022) Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Morgan E. Walker, Joshua B. Simpson & Matthew R. Redinbo. (2022) A structural metagenomics pipeline for examining the gut microbiome. Current Opinion in Structural Biology 75, pages 102416.
Crossref
Crossref
Zehra Esra Ilhan & Melissa M. Herbst-Kralovetz. 2022. Metabolism of Nutrients by Gut Microbiota. Metabolism of Nutrients by Gut Microbiota
120
149
.
Ifeoma Julieth Dikeocha, Abdelkodose Mohammed Al‐Kabsi, Muhammad Miftahussurur & Mohammed Abdullah Alshawsh. (2022) Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. The FASEB Journal 36:6.
Crossref
Crossref
Abdelaziz El Houari, Florine Ecale, Anne Mercier, Stéphanie Crapart, Jérôme Laparre, Baptiste Soulard, Manilduth Ramnath, Jean-Marc Berjeaud, Marie-Hélène Rodier & Alexandre Crépin. (2022) Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics. Frontiers in Microbiology 13.
Crossref
Crossref
Anup P. Challa, Xin Hu, Ya-Qin Zhang, Jeffrey Hymes, Bret D. Wallace, Surendra Karavadhi, Hongmao Sun, Samarjit Patnaik, Matthew D. Hall & Min Shen. (2022) Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity. Journal of Chemical Information and Modeling 62:7, pages 1783-1793.
Crossref
Crossref
Pooja Dhurjad, Chinmayi Dhavaliker, Kajal Gupta & Rajesh Sonti. (2022) Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches. Drug Metabolism and Disposition 50:3, pages 224-234.
Crossref
Crossref
Mingyu Zhang, Feng Xia, Suhong Xia, Wangdong Zhou, Yu Zhang, Xu Han, Kai Zhao, Lina Feng, Ruonan Dong, Dean Tian, Yan Yu & Jiazhi Liao. (2022) NSAID-Associated Small Intestinal Injury: An Overview From Animal Model Development to Pathogenesis, Treatment, and Prevention. Frontiers in Pharmacology 13.
Crossref
Crossref
Daniel A. Schupack, Ruben A. T. Mars, Dayne H. Voelker, Jithma P. Abeykoon & Purna C. Kashyap. (2021) The promise of the gut microbiome as part of individualized treatment strategies. Nature Reviews Gastroenterology & Hepatology 19:1, pages 7-25.
Crossref
Crossref
Aqsa Shahid, Sumreen Hayat, Samman Munir, Usman Ali Ashfaq, Abdul Arif Khan, Muhammad Bilal, Irfan Shaukat & Mohsin Khurshid. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
375
397
.
Yasra Sayyed, Kanwal Rehman, Muhammad Sajid Hamid Akash, Sairah Hafeez Kamran & Mohammad Badran. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
305
321
.
Joanna Nycz & Alicja Zajdel. (2021) Mikrobiota jelitowa a leki. Interakcje wpływające na skuteczność i bezpieczeństwo farmakoterapii. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 762-772.
Crossref
Crossref
Bei Yue, Ruiyang Gao, Cheng Lv, Zhilun Yu, Hao Wang, Xiaolong Geng, Zhengtao Wang & Wei Dou. (2021) Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase. Frontiers in Pharmacology 12.
Crossref
Crossref
Panpan Wang, Yifei Jia, Rongrong Wu, Zhiqiang Chen & Ru Yan. (2021) Human gut bacterial β-glucuronidase inhibition: An emerging approach to manage medication therapy. Biochemical Pharmacology 190, pages 114566.
Crossref
Crossref
Shirley M. Tsunoda, Christopher Gonzales, Alan K. Jarmusch, Jeremiah D. Momper & Joseph D. Ma. (2021) Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability. Clinical Pharmacokinetics 60:8, pages 971-984.
Crossref
Crossref
Yue Bai, Lu Chen, Yun-Feng Cao, Xu-Dong Hou, Shou-Ning Jia, Qi Zhou, Yu-Qi He & Jie Hou. (2021) Beta-Glucuronidase Inhibition by Constituents of Mulberry Bark. Planta Medica 87:08, pages 631-641.
Crossref
Crossref
Xintong Zhang, Ying Han, Wei Huang, Mingji Jin & Zhonggao Gao. (2021) The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B 11:7, pages 1789-1812.
Crossref
Crossref
Aishwarya Naik & Santosh K. Misra. (2021) Modern Sensing Approaches for Predicting Toxicological Responses of Food- and Drug-Based Bioactives on Microbiomes of Gut Origin. Journal of Agricultural and Food Chemistry 69:23, pages 6396-6413.
Crossref
Crossref
Nutthapoom Pathomthongtaweechai & Chatchai Muanprasat. (2021) Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption. Pharmaceutics 13:6, pages 887.
Crossref
Crossref
Guanqun Chao, Jian Dai & Shuo Zhang. (2021) RETRACTED: Protective effect of naringin on small intestine injury in NSAIDs related enteropathy by regulating ghrelin/GHS-R signaling pathway. Life Sciences 266, pages 118909.
Crossref
Crossref
Moamen M. Elmassry, Sunghwan Kim & Ben Busby. (2021) Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes. PLOS ONE 16:1, pages e0244876.
Crossref
Crossref
Makoto Kuji, Nanako Itoh, Yui Ohba, Kiyoshi Yamada & Kei Hashimoto. (2021) Inhibitory effect of 4-ethylcatechol on β-glucuronidase activity. Food Science and Technology Research 27:5, pages 797-806.
Crossref
Crossref
Maria Papageorgiou & Emmanuel Biver. (2021) Interactions of the microbiome with pharmacological and non-pharmacological approaches for the management of ageing-related musculoskeletal diseases. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110090.
Crossref
Crossref
Wuwen Feng, Juan Liu, Lihua Huang, Yuzhu Tan & Cheng Peng. (2021) Gut microbiota as a target to limit toxic effects of traditional Chinese medicine: Implications for therapy. Biomedicine & Pharmacotherapy 133, pages 111047.
Crossref
Crossref
Said R. Bogatyrev, Justin C. Rolando & Rustem F. Ismagilov. (2020) Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine. Microbiome 8:1.
Crossref
Crossref
Samantha M. Ervin, Joshua B. Simpson, Morgan E. Gibbs, Benjamin C. Creekmore, Lauren Lim, William G. Walton, Raad Z. Gharaibeh & Matthew R. Redinbo. (2020) Structural Insights into Endobiotic Reactivation by Human Gut Microbiome-Encoded Sulfatases. Biochemistry 59:40, pages 3939-3950.
Crossref
Crossref
Ara Koh, Louise Mannerås-Holm, Na-Oh Yunn, Peter M. Nilsson, Sung Ho Ryu, Antonio Molinaro, Rosie Perkins, J. Gustav Smith & Fredrik Bäckhed. (2020) Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation. Cell Metabolism 32:4, pages 643-653.e4.
Crossref
Crossref
Ah-Mee Park, Sundar Khadka, Fumitaka Sato, Seiichi Omura, Mitsugu Fujita, Daniel K. Hsu, Fu-Tong Liu & Ikuo Tsunoda. (2020) Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers. Frontiers in Immunology 11.
Crossref
Crossref
Damian Maseda & Emanuela Ricciotti. (2020) NSAID–Gut Microbiota Interactions. Frontiers in Pharmacology 11.
Crossref
Crossref
Stephanie A. Flowers, Shubha Bhat & James C. Lee. (2020) Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:7, pages 704-712.
Crossref
Crossref
Farahnaz Joukar, Sara Mavaddati, Fariborz Mansour-Ghanaei & Ali Akbar Samadani. (2019) Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. Journal of Gastrointestinal Cancer 51:2, pages 363-378.
Crossref
Crossref
Punsaldulam Dashnyam, Hsien-Ya Lin, Chia-Yu Chen, Shijay Gao, Lun-Fu Yeh, Wei-Che Hsieh, Zhijay Tu & Chun-Hung Lin. (2020) Substituent Position of Iminocyclitols Determines the Potency and Selectivity for Gut Microbial Xenobiotic-Reactivating Enzymes. Journal of Medicinal Chemistry 63:9, pages 4617-4627.
Crossref
Crossref
Nehal Adel Abdelsalam, Ahmed Tarek Ramadan, Marwa Tarek ElRakaiby & Ramy Karam Aziz. (2020) Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics. Frontiers in Pharmacology 11.
Crossref
Crossref
Aadra P. Bhatt, Samuel J. Pellock, Kristen A. BiernatWilliam G. WaltonBret D. WallaceBenjamin C. CreekmoreMarine M. LetertreJonathan R. SwannIan D. WilsonJose R. RoquesDavid B. DarrSean T. BaileyStephanie A. MontgomeryJeffrey M. Roach, M. Andrea Azcarate-Peril, R. Balfour Sartor, Raad Z. GharaibehScott J. BultmanMatthew R. Redinbo. (2020) Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy. Proceedings of the National Academy of Sciences 117:13, pages 7374-7381.
Crossref
Crossref
Samantha M. Ervin, Siddharth Venkat Ramanan & Aadra P. Bhatt. (2020) Relationship Between the Gut Microbiome and Systemic Chemotherapy. Digestive Diseases and Sciences 65:3, pages 874-884.
Crossref
Crossref
Paul Awolade, Nosipho Cele, Nagaraju Kerru, Lalitha Gummidi, Ebenezer Oluwakemi & Parvesh Singh. (2020) Therapeutic significance of β-glucuronidase activity and its inhibitors: A review. European Journal of Medicinal Chemistry 187, pages 111921.
Crossref
Crossref
Parth B. Jariwala, Samuel J. Pellock, Dennis Goldfarb, Erica W. Cloer, Marta Artola, Joshua B. Simpson, Aadra P. Bhatt, William G. Walton, Lee R. Roberts, Michael B. Major, Gideon J. Davies, Herman S. Overkleeft & Matthew R. Redinbo. (2019) Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling. ACS Chemical Biology 15:1, pages 217-225.
Crossref
Crossref
Samantha M. Ervin, Ronan P. Hanley, Lauren Lim, William G. Walton, Kenneth H. Pearce, Aadra P. Bhatt, Lindsey I. James & Matthew R. Redinbo. (2019) Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases. ACS Chemical Biology 14:12, pages 2737-2744.
Crossref
Crossref
Samantha M. Ervin, Hao Li, Lauren Lim, Lee R. Roberts, Xue Liang, Sridhar Mani & Matthew R. Redinbo. (2019) Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. Journal of Biological Chemistry 294:49, pages 18586-18599.
Crossref
Crossref
Chaonan Sun, Ling Chen & Zhu Shen. (2019) Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice. Saudi Pharmaceutical Journal 27:8, pages 1146-1156.
Crossref
Crossref
Shabnam Murshid & Gnana Prakash Dhakshinamoorthy. (2019) Biodegradation of Sodium Diclofenac and Mefenamic Acid: Kinetic studies, identification of metabolites and analysis of enzyme activity. International Biodeterioration & Biodegradation 144, pages 104756.
Crossref
Crossref
Scott T. EspenschiedMark R. CronanMolly A. MattyOlaf MuellerMatthew R. RedinboDavid M. Tobin & John F. Rawls. (2019) Epithelial delamination is protective during pharmaceutical-induced enteropathy. Proceedings of the National Academy of Sciences 116:34, pages 16961-16970.
Crossref
Crossref
Reese Hitchings & Libusha Kelly. (2019) Predicting and Understanding the Human Microbiome’s Impact on Pharmacology. Trends in Pharmacological Sciences 40:7, pages 495-505.
Crossref
Crossref
Tara R. Catron, Adam Swank, Leah C. Wehmas, Drake Phelps, Scott P. Keely, Nichole E. Brinkman, James McCord, Randolph Singh, Jon Sobus, Charles E. Wood, Mark Strynar, Emily Wheaton & Tamara Tal. (2019) Microbiota alter metabolism and mediate neurodevelopmental toxicity of 17β-estradiol. Scientific Reports 9:1.
Crossref
Crossref
Juanhong Zhang, Junmin Zhang, Rong Wang & Zhengping Jia. (2019) Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes. Current Drug Metabolism 20:2, pages 155-165.
Crossref
Crossref
Gerard Clarke, Kiran V. Sandhu, Brendan T. Griffin, Timothy G. Dinan, John F. Cryan & Niall P. Hyland. (2019) Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions. Pharmacological Reviews 71:2, pages 198-224.
Crossref
Crossref
Wuwen Feng, Hui Ao, Cheng Peng & Dan Yan. (2019) Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacological Research 142, pages 176-191.
Crossref
Crossref
Samuel J. Pellock, William G. Walton & Matthew R. Redinbo. (2019) Selecting a Single Stereocenter: The Molecular Nuances That Differentiate β-Hexuronidases in the Human Gut Microbiome. Biochemistry 58:9, pages 1311-1317.
Crossref
Crossref
W. H. Wilson Tang, Daniel Y. Li & Stanley L. Hazen. (2018) Dietary metabolism, the gut microbiome, and heart failure. Nature Reviews Cardiology 16:3, pages 137-154.
Crossref
Crossref
Samuel J. Pellock, William G. Walton, Samantha M. Ervin, Dariana Torres-Rivera, Benjamin C. Creekmore, Grace Bergan, Zachary D. Dunn, Bo Li, Ashutosh Tripathy & Matthew R. Redinbo. (2019) Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome. Journal of Molecular Biology 431:5, pages 970-980.
Crossref
Crossref
Kristen A. Biernat, Samuel J. Pellock, Aadra P. Bhatt, Marissa M. Bivins, William G. Walton, Bich Ngoc T. Tran, Lianjie Wei, Michael C. Snider, Andrew P. Cesmat, Ashutosh Tripathy, Dorothy A. Erie & Matthew R. Redinbo. (2019) Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases. Scientific Reports 9:1.
Crossref
Crossref
Kai-Wen Cheng, Chih-Hua Tseng, Cherng-Chyi Tzeng, Yu-Lin Leu, Ta-Chun Cheng, Jaw-Yuan Wang, Jia-Ming Chang, Yun-Chi Lu, Chiu-Min Cheng, I-Ju Chen, Yi-An Cheng, Yeh-Long Chen & Tian-Lu Cheng. (2019) Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacological Research 139, pages 41-49.
Crossref
Crossref
Aries Chavira, Pedro Belda-Ferre, Tomasz Kosciolek, Farhana Ali, Pieter C. Dorrestein & Rob Knight. 2019. Concepts and Principles of Pharmacology. Concepts and Principles of Pharmacology
301
326
.
Jacinta Walsh, Brendan T Griffin, Gerard Clarke & Niall P Hyland. (2018) Drug–gut microbiota interactions: implications for neuropharmacology. British Journal of Pharmacology 175:24, pages 4415-4429.
Crossref
Crossref
Michael S. Little, Samantha M. Ervin, William G. Walton, Ashutosh Tripathy, Yongmei Xu, Jian Liu & Matthew R. Redinbo. (2018)
Active site flexibility revealed in crystal structures of
Parabacteroides merdae
β‐glucuronidase from the human gut microbiome
. Protein Science 27:12, pages 2010-2022.
Crossref
Crossref
Samuel J. Pellock, William G. Walton, Kristen A. Biernat, Dariana Torres-Rivera, Benjamin C. Creekmore, Yongmei Xu, Jian Liu, Ashutosh Tripathy, Lance J. Stewart & Matthew R. Redinbo. (2018) Three structurally and functionally distinct β-glucuronidases from the human gut microbe Bacteroides uniformis. Journal of Biological Chemistry 293:48, pages 18559-18573.
Crossref
Crossref
Lei Feng, Yongliang Yang, Xiaokui Huo, Xiangge Tian, Yujie Feng, Hanwen Yuan, Lijian Zhao, Chao Wang, Peng Chu, Feida Long, Wei Wang & Xiaochi Ma. (2018) Highly Selective NIR Probe for Intestinal β-Glucuronidase and High-Throughput Screening Inhibitors to Therapy Intestinal Damage. ACS Sensors 3:9, pages 1727-1734.
Crossref
Crossref
Samuel J. Pellock, Benjamin C. Creekmore, William G. Walton, Naimee Mehta, Kristen A. Biernat, Andrew P. Cesmat, Yamuna Ariyarathna, Zachary D. Dunn, Bo Li, Jian Jin, Lindsey I. James & Matthew R. Redinbo. (2018) Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception. ACS Central Science 4:7, pages 868-879.
Crossref
Crossref
Simon T.K. YauwMelissa ArronRoger M.L.M. LommePetra van den BroekRick GreupinkAadra P. BhattMatthew R. RedinboHarry van Goor. (2018) Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak in Rats. Surgical Infections 19:4, pages 417-423.
Crossref
Crossref
Ingvar Bjarnason, Carmelo Scarpignato, Erik Holmgren, Michael Olszewski, Kim D. Rainsford & Angel Lanas. (2018) Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. Gastroenterology 154:3, pages 500-514.
Crossref
Crossref
Purna C Kashyap & Eamonn MM Quigley. (2018) Therapeutic implications of the gastrointestinal microbiome. Current Opinion in Pharmacology 38, pages 90-96.
Crossref
Crossref
Austin Yan, Elizabeth Culp, Julie Perry, Jennifer T. Lau, Lesley T. MacNeil, Michael G. Surette & Gerard D. Wright. (2017) Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome. ACS Infectious Diseases 4:1, pages 68-76.
Crossref
Crossref
Aadra P. Bhatt, Dulan B. Gunasekara, Jennifer Speer, Mark I. Reed, Alexis N. Peña, Bentley R. Midkiff, Scott T. Magness, Scott J. Bultman, Nancy L. Allbritton & Matthew R. Redinbo. (2017) Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells. ACS Infectious Diseases 4:1, pages 46-52.
Crossref
Crossref
Michael S. LittleSamuel J. PellockWilliam G. WaltonAshutosh TripathyMatthew R. Redinbo. (2017) Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae. Proceedings of the National Academy of Sciences 115:2.
Crossref
Crossref
M. Holsapple, R. Prell & S. Comstock. 2018. Comprehensive Toxicology. Comprehensive Toxicology
467
497
.
Katrin Hochrath & Bernd Schnabl. (2017) Check your microbiota when taking the drug. Hepatology 67:1, pages 18-20.
Crossref
Crossref
Keumhan Noh, You Ra Kang, Mahesh Raj Nepal, Rajina Shakya, Mi Jeong Kang, Wonku Kang, Sangkyu Lee, Hye Gwang Jeong & Tae Cheon Jeong. (2017) Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs. Archives of Pharmacal Research 40:12, pages 1345-1355.
Crossref
Crossref
Yuichi Yasutake, Kengo Tomita, Masaaki Higashiyama, Hirotaka Furuhashi, Kazuhiko Shirakabe, Takeshi Takajo, Koji Maruta, Hirokazu Sato, Kazuyuki Narimatsu, Kenichi Yoshikawa, Yoshikiyo Okada, Chie Kurihara, Chikako Watanabe, Shunsuke Komoto, Shigeaki Nagao, Hirotaka Matsuo, Soichiro Miura & Ryota Hokari. (2017) Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity. Journal of Gastroenterology and Hepatology 32:11, pages 1839-1845.
Crossref
Crossref
Zi-Miao Weng, Ping Wang, Guang-Bo Ge, Zi-Ru Dai, Da-Chang Wu, Li-Wei Zou, Tong-Yi Dou, Tong-Yan Zhang, Ling Yang & Jie Hou. (2017) Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase. Food and Chemical Toxicology 109, pages 975-983.
Crossref
Crossref
Rebecca M. Pollet, Emma H. D'Agostino, William G. Walton, Yongmei Xu, Michael S. Little, Kristen A. Biernat, Samuel J. Pellock, Loraine M. Patterson, Benjamin C. Creekmore, Hanna N. Isenberg, Rohini R. Bahethi, Aadra P. Bhatt, Jian Liu, Raad Z. Gharaibeh & Matthew R. Redinbo. (2017) An Atlas of β-Glucuronidases in the Human Intestinal Microbiome. Structure 25:7, pages 967-977.e5.
Crossref
Crossref
Yuseok Moon. (2017) NSAID-activated gene 1 and its implications for mucosal integrity and intervention beyond NSAIDs. Pharmacological Research 121, pages 122-128.
Crossref
Crossref
Nitzan Koppel, Vayu Maini Rekdal & Emily P. Balskus. (2017) Chemical transformation of xenobiotics by the human gut microbiota. Science 356:6344.
Crossref
Crossref
Samuel J. Pellock & Matthew R. Redinbo. (2017) Glucuronides in the gut: Sugar-driven symbioses between microbe and host. Journal of Biological Chemistry 292:21, pages 8569-8576.
Crossref
Crossref
Pierre-André Billat, Emilie Roger, Sébastien Faure & Frédéric Lagarce. (2017) Models for drug absorption from the small intestine: where are we and where are we going?. Drug Discovery Today 22:5, pages 761-775.
Crossref
Crossref
Ian D. Wilson & Jeremy K. Nicholson. (2017) Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research 179, pages 204-222.
Crossref
Crossref
Sridhar Mani. 2017. Approaches to Understanding Breast Cancer. Approaches to Understanding Breast Cancer
217
229
.
Ze-yu Zhong, Bin-bin Sun, Nan Shu, Qiu-shi Xie, Xian-ge Tang, Zhao-li Ling, Fan Wang, Kai-jing Zhao, Ping Xu, Mian Zhang, Ying Li, Yang Chen, Li Liu, Lun-zhu Xia & Xiao-dong Liu. (2016) Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity. Acta Pharmacologica Sinica 37:7, pages 1002-1012.
Crossref
Crossref
Peter Spanogiannopoulos, Elizabeth N. Bess, Rachel N. Carmody & Peter J. Turnbaugh. (2016) The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nature Reviews Microbiology 14:5, pages 273-287.
Crossref
Crossref
Matteo Fornai, Luca Antonioli, Carolina Pellegrini, Rocchina Colucci, Deborah Sacco, Erika Tirotta, Gianfranco Natale, Alessia Bartalucci, Marina Flaibani, Cecilia Renzulli, Emilia Ghelardi, Corrado Blandizzi & Carmelo Scarpignato. (2016) Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic. Pharmacological Research 104, pages 186-196.
Crossref
Crossref
Claire J Steves, Sarah Bird, Frances MK Williams & Tim D Spector. (2016) The Microbiome and Musculoskeletal Conditions of Aging: A Review of Evidence for Impact and Potential Therapeutics. Journal of Bone and Mineral Research 31:2, pages 261-269.
Crossref
Crossref
Mohammad Yaghoobi & Richard H. Hunt. 2016. NSAIDs and Aspirin. NSAIDs and Aspirin
91
104
.
Xue Liang, Kyle Bittinger, Xuanwen Li, Darrell R Abernethy, Frederic D Bushman & Garret A FitzGerald. (2015) Bidirectional interactions between indomethacin and the murine intestinal microbiota. eLife 4.
Crossref
Crossref
Curtis D. Klaassen & Julia Yue Cui. (2015) Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metabolism and Disposition 43:10, pages 1505-1521.
Crossref
Crossref
Lian Yee Yip & Eric Chun Yong Chan. (2015) Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome. Drug Metabolism and Disposition 43:10, pages 1619-1631.
Crossref
Crossref
Bret D. Wallace, Adam B. Roberts, Rebecca M. Pollet, James D. Ingle, Kristen A. Biernat, Samuel J. Pellock, Madhu Kumar Venkatesh, Leah Guthrie, Sara K. O’Neal, Sara J. Robinson, Makani Dollinger, Esteban Figueroa, Sarah R. McShane, Rachel D. Cohen, Jian Jin, Stephen V. Frye, William C. Zamboni, Charles Pepe-Ranney, Sridhar Mani, Libusha Kelly & Matthew R. Redinbo. (2015) Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. Chemistry & Biology 22:9, pages 1238-1249.
Crossref
Crossref
Rory W. BlacklerGiada De PalmaAnna MankoGabriela J. Da SilvaKyle L. FlanniganPremysl BercikMichael G. SuretteAndre G. Buret & John L. Wallace. (2015) Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. American Journal of Physiology-Gastrointestinal and Liver Physiology 308:12, pages G994-G1003.
Crossref
Crossref
Elizabeth J. Dial, Paul A. Dawson & Lenard M. Lichtenberger. (2015) In vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 308:3, pages G217-G222.
Crossref
Crossref
Rory W Blackler, Jean-Paul Motta, Anna Manko, Matthew Workentine, Premysl Bercik, Michael G Surette & John L Wallace. (2015) Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. British Journal of Pharmacology 172:4, pages 992-1004.
Crossref
Crossref
Ian D. Wilson & Jeremy K. Nicholson. 2015. Metabonomics and Gut Microbiota in Nutrition and Disease. Metabonomics and Gut Microbiota in Nutrition and Disease
323
341
.
Rory W Blackler, Burcu Gemici, Anna Manko & John L Wallace. (2014) NSAID-gastroenteropathy: new aspects of pathogenesis and prevention. Current Opinion in Pharmacology 19, pages 11-16.
Crossref
Crossref
Matthew R. Redinbo. (2014) The Microbiota, Chemical Symbiosis, and Human Disease. Journal of Molecular Biology 426:23, pages 3877-3891.
Crossref
Crossref
Andrew D. Patterson & Peter J. Turnbaugh. (2014) Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology. Cell Metabolism 20:5, pages 761-768.
Crossref
Crossref
Rachel N. Carmody & Peter J. Turnbaugh. (2014) Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. Journal of Clinical Investigation 124:10, pages 4173-4181.
Crossref
Crossref
Cynthia L. Sears & Wendy S. Garrett. (2014) Microbes, Microbiota, and Colon Cancer. Cell Host & Microbe 15:3, pages 317-328.
Crossref
Crossref
Sridhar Mani, Urs A. Boelsterli & Matthew R. Redinbo. (2014) Understanding and Modulating Mammalian-Microbial Communication for Improved Human Health. Annual Review of Pharmacology and Toxicology 54:1, pages 559-580.
Crossref
Crossref